e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Asthma and COPD: medication and management in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New soft mist inhaler is effective and easy to use in patients with asthma and COPD
P. Kardos, W. Golisch, K. Wolf (Frankfurt, Ingelheim, Germany)
Source:
Annual Congress 2005 - Asthma and COPD: medication and management in primary care
Session:
Asthma and COPD: medication and management in primary care
Session type:
Thematic Poster Session
Number:
2213
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kardos, W. Golisch, K. Wolf (Frankfurt, Ingelheim, Germany). New soft mist inhaler is effective and easy to use in patients with asthma and COPD. Eur Respir J 2005; 26: Suppl. 49, 2213
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Preference for novel soft mist inhaler over pMDI in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 88s
Year: 2004
Description of the UK’s asthma and COPD inhaler use
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005
Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 121s
Year: 2001
A digital inhaler uncovering patterns of SABA use in asthma and COPD
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Inhaler choice in primary practice
Source: Eur Respir Rev 2005; 14: 117-122
Year: 2005
How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Investigating inhaler technique in patients with COPD using different aids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006
Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018
Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016
The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept